Intas Pharmaceuticals Ltd

Fortune 500 2023
+ 2 More
+ 2 More
OVERVIEW
FINANCIALS

Featured In Fortune India Ranking

Fortune 500 India
#176(2023)
#102(2022)
#138(2021)
#176(2023)#102(2022)#138(2021)
Ranking Trend Fortune 500 India

Financial Data 2023

Revenue
19,702
(INR Cr)
Net Operating Income
19,883
(INR Cr)
Assets
19,956
(INR Cr)
Profit
2,423
(INR Cr)
Net Worth
17,227
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS202320222021202020192018201720162015201420132012201120102009
Revenue
(INR Cr)
19702
5.4%
18691
11.1%
16823
67.1%
10068
16.2%
8666
18.4%
7322
11.3%
6579
12.9%
5826
10.0%
5296
19.4%
4437
23.7%
3586
22.1%
2938
37.7%
2134
30.1%
1640
27.9%
1282
-
Net Operating Income
(INR Cr)
19883
8.35%
18351
11.53%
16454
0.00%
9583
14.32%
8382
18.04%
7102
10.82%
6408
14.22%
5611
27.90%
5117
22.40%
4181
17.36%
3563
28.73%
2767
43.11%
1934
21.53%
1591
0.00%
1156
22.11%
Profit
(INR Cr)
2423
-9.6%
2679
17.0%
2290
50.8%
1519
24.4%
1221
-1.1%
1234
19.2%
1036
-3.3%
1071
74.5%
614
16.6%
526
35.2%
389
35.0%
288
27.7%
226
14.5%
197
70.1%
116
-
Assets
(INR Cr)
19956
10.3%
18098
-1.8%
18427
40.6%
13109
14.7%
11428
16.5%
9812
18.1%
8307
57.0%
5292
44.6%
3659
20.8%
3029
12.2%
2700
5.8%
2551
21.8%
2095
93.0%
1085
28.0%
848
-
Net Worth
(INR Cr)
17227
17.3%
14681
21.1%
12121
0.0%
9974
15.9%
8604
16.1%
7409
18.9%
6231
20.0%
5194
23.7%
2803
25.5%
2233
27.2%
1755
48.4%
1183
21.7%
972
70.7%
570
0.0%
439
36.0%
Employee Cost
(INR Cr)
3363
14.4%
2940
13.4%
2593
95.3%
1327
14.4%
1161
21.4%
956
18.1%
809
23.2%
657
-0.9%
663
24.8%
531
21.4%
438
24.9%
350
44.4%
243
36.8%
177
124.0%
79
-
Interest Cost
(INR Cr)
12611126717729115361826406095523323
Cash & Bank Balance
(INR Cr)
3436225432822562972302475895736524516
Total Debt
(INR Cr)
146423595243294826362250195947777058631166974507408

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS202320222021202020192018201720162015201420132012201120102009
Profit As % Of Revenues 12.3%14.3%13.6%15.1%14.1%16.9%15.7%18.4%11.6%11.9%10.9%9.8%10.6%12.0%9.1%
Profit As % Of Assets 12.1%14.8%12.4%11.6%10.7%12.6%12.5%20.2%16.8%17.4%14.4%11.3%10.8%18.2%13.7%
Profit As % Of Networth 14.1%18.3%18.9%15.2%14.2%16.7%16.6%20.6%21.9%23.6%22.2%24.4%23.2%34.6%26.4%
Interest Cost to EBITDA % 3.4%2.8%7.2%8.2%1.6%6.1%2.3%1.1%2.9%5.6%9.2%18.4%16.1%12.2%31.2%
Debt to Equity Ratio 0.080.160.430.300.310.300.310.000.280.320.490.991.000.890.93
RONW 15.2%20.0%18.9%16.4%15.2%18.1%18.1%22.8%24.6%26.9%32.1%25.9%27.7%35.0%30.4%
ROCE 16.7%18.6%16.8%18.1%15.1%18.8%20.1%27.1%25.3%26.8%25.6%20.1%19.3%24.4%21.0%